Analyzing recently published data on genomic alterations related to annotated genes for a 102-cohort [23], reveals that loss of chr16q22.2 (containing DHODH) is amongst the most frequent alterations in retinoblastoma and comparable to MYCN and MDM4 gain/amplification (Supplementary Table 1). This evidence concerns the gene MDM4 and retinoblastoma.